blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1446733

EP1446733 - GLYCOSYLPHOSPHATIDYLINOSITOL CONTAINING POLYPEPTIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.07.2010
Database last updated on 02.09.2024
Most recent event   Tooltip11.03.2011Lapse of the patent in a contracting state
New state(s): BG
published on 13.04.2011  [2011/15]
Applicant(s)For all designated states
Asterion Limited
Firth Court, Western Bank
Sheffield S10 2TN / GB
[2009/37]
Former [2004/34]For all designated states
Asterion Limited
Firth Court, Western Bank
Sheffield S10 2TN / GB
Inventor(s)01 / ROSS, Richard
University of Sheffield Room 112 Floor M Royal Hallamshire Hospital Glossop Road
Sheffield S10 2JF GB / GB
 [2009/35]
Former [2004/34]01 / ROSS, Richard
Chemical Sciences, Northern General Hospital
Sheffield S5 7ALL / GB
Representative(s)Harrison IP Limited
3 Ebor House
Millfield Lane
Nether Poppleton
York YO26 6QY / GB
[N/P]
Former [2007/07]Gilholm Harrison Ltd
Marlborough House Westminster Place York Business Park
Nether Poppleton, York YO26 6RW / GB
Former [2006/46]Boakes, Jason Carrington
Harrison Goddard Foote 31 St Saviourgate
York YO1 8NQ / GB
Application number, filing date02801405.811.10.2002
[2004/34]
WO2002GB04665
Priority number, dateGB2001002462013.10.2001         Original published format: GB 0124620
GB2002000090416.01.2002         Original published format: GB 0200904
GB2002001888914.08.2002         Original published format: GB 0218889
[2004/34]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03034275
Date:24.04.2003
Language:EN
[2003/17]
Type: A2 Application without search report 
No.:EP1446733
Date:18.08.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 24.04.2003 takes the place of the publication of the European patent application.
[2004/34]
Type: B1 Patent specification 
No.:EP1446733
Date:09.09.2009
Language:EN
[2009/37]
Search report(s)International search report - published on:EP27.11.2003
ClassificationIPC:C12N15/62, C07K14/72
[2009/12]
CPC data not yet available
Former IPC [2009/08]C12N15/62
Former IPC [2004/34]G06F17/28
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/34]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:GLYKOSYLPHOSPHATIDYLINOSITOLHALTIGE POLYPEPTIDE[2004/34]
English:GLYCOSYLPHOSPHATIDYLINOSITOL CONTAINING POLYPEPTIDES[2004/34]
French:POLYPEPTIDES CONTENANT DU GLYCOSYLPHOSPHATIDYLINOSITOL[2004/34]
Entry into regional phase24.03.2004National basic fee paid 
24.03.2004Designation fee(s) paid 
24.03.2004Examination fee paid 
Examination procedure02.05.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
24.03.2004Examination requested  [2004/34]
08.10.2007Despatch of a communication from the examining division (Time limit: M06)
02.04.2008Reply to a communication from the examining division
09.06.2008Despatch of a communication from the examining division (Time limit: M06)
08.12.2008Reply to a communication from the examining division
06.04.2009Communication of intention to grant the patent
22.07.2009Fee for grant paid
22.07.2009Fee for publishing/printing paid
Opposition(s)10.06.2010No opposition filed within time limit [2010/33]
Fees paidRenewal fee
05.11.2004Renewal fee patent year 03
06.09.2005Renewal fee patent year 04
13.10.2006Renewal fee patent year 05
24.10.2007Renewal fee patent year 06
24.09.2008Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.10.200403   M06   Fee paid on   05.11.2004
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY09.09.2009
EE09.09.2009
SK09.09.2009
BG31.10.2009
MC31.10.2009
[2011/15]
Former [2010/25]CY09.09.2009
EE09.09.2009
SK09.09.2009
MC31.10.2009
Former [2010/24]CY09.09.2009
EE09.09.2009
SK09.09.2009
Former [2010/20]CY09.09.2009
EE09.09.2009
Former [2010/16]CY09.09.2009
Cited inInternational search[X]WO9900423  (IMMUNEX CORP [US]) [X] 1,2,4,7,8,12-18,20-25,27,28 * page 1, line 26 - page 2, line 20 * * page 3, line 21 - line 29 * * page 21, line 17 - line 20 * * page 24, line 33 *;
 [X]EP0976764  (CHUGAI RES INST MOLECULAR MED [JP]) [X] 1,2,4,7,8,12-18,21,23,24,28 * page 2, line 30 - page 3, line 46 *;
 [X]WO0056862  (HUMAN GENOME SCIENCES INC [US], et al) [X] 9-27 * page 3 - page 7; figure 2 *;
 [YD]  - ROSS R J M ET AL, "A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein", MOLECULAR ENDOCRINOLOGY, BALTIMORE, MD, US, (1997), vol. 11, no. 3, ISSN 0888-8809, pages 265 - 273, XP002181691 [YD] 5,6,9-11 * page 269, column 2 - page 271, column 2 *

DOI:   http://dx.doi.org/10.1210/me.11.3.265
 [Y]  - DA COSTA CLIVE R ET AL, "Production of the thyrotrophin receptor extracellular domain as a glycosylphosphatidylinositol-anchored membrane protein and its interaction with thyrotrophin and autoantibodies.", JOURNAL OF BIOLOGICAL CHEMISTRY, (19980508), vol. 273, no. 19, ISSN 0021-9258, pages 11874 - 11880, XP002246413 [Y] 5,6,9-11 * abstract *

DOI:   http://dx.doi.org/10.1074/jbc.273.19.11874
 [A]  - MAAMRA MABROUKA ET AL, "Studies with a growth hormone antagonist and dual-fluorescent confocal microscopy demonstrate that the full-length human growth hormone receptor, but not the truncated isoform, is very rapidly internalized independent of Jak2-Stat5 signaling.", JOURNAL OF BIOLOGICAL CHEMISTRY, (19990521), vol. 274, no. 21, ISSN 0021-9258, pages 14791 - 14798, XP002246414 [A] 1,28 * page 14791, column 1 - column 2 *

DOI:   http://dx.doi.org/10.1074/jbc.274.21.14791
 [A]  - R.A. MEYERS (ED.), Molecular Biology and Biotechnology. A comprehensive desk reference, NEW YORK, US, VCH PUBLISHERS, INC., (1995), XP002246550 [A] 1-28 * page 200 - page 204 * * page 392 - page 397 * * page 474 - page 476 * * page 789 - page 793 *
ExaminationEP1081224
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.